Ageing in fibroblasts induced Enhancer of zeste homolog 2 (EZH2) decline and increased Bone Morphogenetic Protein 2 (BMP2) secretion, these mechanisms induce slower-cycling, highly invasive and therapy-resistant melanomas. The gene discussed is BMP2; the disease is melanoma.